NYSE:MRK - Merck & Co., Inc. Stock Price, Price Target & More

Merck & Co., Inc. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRK."

Merck & Co., Inc. announced a quarterly dividend on Tuesday, May 22nd. Shareholders of record on Friday, June 15th will be paid a dividend of $0.48 per share on Monday, July 9th. This represents a $1.92 annualized dividend and a yield of 3.05%. The ex-dividend date is Thursday, June 14th. View Merck & Co., Inc.'s Dividend History.

Merck & Co., Inc. announced that its Board of Directors has approved a share repurchase plan on Saturday, December 2nd 2017, which permits the company to repurchase $10,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its shares are undervalued.

Merck & Co., Inc. (NYSE:MRK) released its quarterly earnings data on Tuesday, May, 1st. The company reported $1.05 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.00 by $0.05. The company had revenue of $10.04 billion for the quarter, compared to analysts' expectations of $10.09 billion. Merck & Co., Inc. had a net margin of 4.31% and a return on equity of 30.93%. The firm's revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.88 earnings per share. View Merck & Co., Inc.'s Earnings History.

Merck & Co., Inc. is scheduled to release their next quarterly earnings announcement on Friday, July, 27th 2018. View Earnings Estimates for Merck & Co., Inc..

Merck & Co., Inc. issued an update on its FY18 earnings guidance on Tuesday, May, 1st. The company provided earnings per share guidance of $4.16-4.28 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.19. The company issued revenue guidance of $41.8-43.0 billion, compared to the consensus revenue estimate of $41.86 billion.

18 brokers have issued 1 year price targets for Merck & Co., Inc.'s shares. Their predictions range from $58.83 to $72.00. On average, they anticipate Merck & Co., Inc.'s stock price to reach $66.0519 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price. View Analyst Ratings for Merck & Co., Inc..

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck & Co., Inc. in the last year. There are currently 4 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Merck & Co., Inc. saw a decrease in short interest in the month of June. As of June 29th, there was short interest totalling 17,153,866 shares, a decrease of 21.6% from the June 15th total of 21,867,505 shares. Based on an average trading volume of 11,109,077 shares, the days-to-cover ratio is currently 1.5 days. Approximately 0.6% of the company's shares are sold short. View Merck & Co., Inc.'s Current Options Chain.

Some companies that are related to Merck & Co., Inc. include Johnson & Johnson (JNJ), Pfizer (PFE), Novartis (NVS), AbbVie (ABBV), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT), Sanofi (SNY), GlaxoSmithKline (GSK), Eli Lilly And Co (LLY), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG), Allergan (AGN) and Shire (SHPG).

Media stories about MRK stock have trended somewhat positive on Wednesday, Accern reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Merck & Co., Inc. earned a news sentiment score of 0.03 on Accern's scale. They also assigned media coverage about the company an impact score of 46.61 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Merck & Co., Inc.'s stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (0.29%), Swedbank (0.15%), Bank of Montreal Can (0.14%), NN Investment Partners Holdings N.V. (0.08%), Retirement Systems of Alabama (0.08%) and Manning & Napier Group LLC (0.07%). Company insiders that own Merck & Co., Inc. stock include Adam H Schechter, C Robert Kidder, Clark Golestani, Julie L Gerberding, Kenneth C Frazier, Michael J Holston, Patricia F Russo, Rochelle B Lazarus, Thomas H Glocer, Thomas R Cech, Weir Mirian M Graddick and Wendell P Weeks. View Institutional Ownership Trends for Merck & Co., Inc..

MRK stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Manning & Napier Group LLC, Radnor Capital Management LLC, Highland Capital Management LLC, Clinton Group Inc., Fulton Bank N.A. and Deprince Race & Zollo Inc.. Company insiders that have sold Merck & Co., Inc. company stock in the last year include Adam H Schechter, Julie L Gerberding, Michael J Holston, Thomas H Glocer, Weir Mirian M Graddick and Wendell P Weeks. View Insider Buying and Selling for Merck & Co., Inc..

MRK stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Gateway Investment Advisers LLC, LGT Capital Partners LTD., Retirement Systems of Alabama, Calamos Advisors LLC, DnB Asset Management AS, Welch & Forbes LLC and Handelsbanken Fonder AB. View Insider Buying and Selling for Merck & Co., Inc..

Shares of MRK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MRK stock can currently be purchased for approximately $62.94.

Merck & Co., Inc. has a market capitalization of $168.75 billion and generates $40.12 billion in revenue each year. The company earns $2.39 billion in net income (profit) each year or $3.98 on an earnings per share basis. Merck & Co., Inc. employs 69,000 workers across the globe.

Merck & Co., Inc.'s mailing address is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. The company can be reached via phone at 908-740-4000 or via email at [email protected]